# Forbion Capital Partners' Biotech Investments: 54 Startups in Its Portfolio (2026) > The 54 Biotech startups Forbion Capital Partners has backed, by stage: $7.0B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/forbion-capital-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 23 - [Expedition Therapeutics](https://millionrounds.com/company/expedition-therapeutics) - [Marea Therapeutics](https://millionrounds.com/company/marea-therapeutics) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [Mariana Oncology](https://millionrounds.com/company/mariana-oncology) - [AIRNA](https://millionrounds.com/company/airna) - [Noema Pharma](https://millionrounds.com/company/noema-pharma) - [Achilles Therapeutics](https://millionrounds.com/company/achilles-therapeutics) - [AAVantgarde Bio](https://millionrounds.com/company/aavantgarde-bio) - [Purespring Therapeutics](https://millionrounds.com/company/purespring-therapeutics) - [Pheon Therapeutics](https://millionrounds.com/company/pheon-therapeutics) - [Milestone Pharmaceuticals](https://millionrounds.com/company/milestone-pharmaceuticals) - [SynOx Therapeutics](https://millionrounds.com/company/synox-therapeutics) - [Citryll](https://millionrounds.com/company/citryll) - [Precirix](https://millionrounds.com/company/precirix) - [*R* Replimune](https://millionrounds.com/company/replimune) - [Exosome Diagnostics](https://millionrounds.com/company/exosome-diagnostics) - [NeRRe Therapeutics](https://millionrounds.com/company/nerre-therapeutics) - [*GB* Granite Bio](https://millionrounds.com/company/granite-bio) - [Gate Bioscience](https://millionrounds.com/company/gate-bioscience) - [*AT* Allecra Therapeutics](https://millionrounds.com/company/allecra-therapeutics) - [Prexton Therapeutics](https://millionrounds.com/company/prexton-therapeutics) - [*E* Escalier](https://millionrounds.com/company/escalier) - [*AT* Akarna Therapeutics](https://millionrounds.com/company/akarna-therapeutics) ## Series A 16 - [Dyne Therapeutics](https://millionrounds.com/company/dyne-therapeutics) - [Verdiva Bio](https://millionrounds.com/company/verdiva-bio) - [Braveheart Bio](https://millionrounds.com/company/braveheart-bio) - [Slate Medicines](https://millionrounds.com/company/slate-medicines) - [*MM* Memento Medicines](https://millionrounds.com/company/memento-medicines) - [Calluna Pharma](https://millionrounds.com/company/calluna-pharma) - [Corsera Health](https://millionrounds.com/company/corsera-health) - [*MT* Mosanna Therapeutics](https://millionrounds.com/company/mosanna-therapeutics) - [Complement Therapeutics](https://millionrounds.com/company/complement-therapeutics) - [*PT* Progentos Therapeutics](https://millionrounds.com/company/progentos-therapeutics) - [Kynexis](https://millionrounds.com/company/kynexis) - [*G* Gotham](https://millionrounds.com/company/gotham) - [Dualyx](https://millionrounds.com/company/dualyx) - [Pact](https://millionrounds.com/company/pact) - [*C* Cardoz](https://millionrounds.com/company/cardoz) - [*R* Rigontec](https://millionrounds.com/company/rigontec) ## Series C and later 7 - [Beacon Therapeutics](https://millionrounds.com/company/beacon-therapeutics) - [AM Pharma](https://millionrounds.com/company/am-pharma) - [*B* BioVex](https://millionrounds.com/company/biovex) - [SANIFIT](https://millionrounds.com/company/sanifit) - [NorthSea Therapeutics](https://millionrounds.com/company/northsea-therapeutics) - [Hookipa](https://millionrounds.com/company/hookipa) - [*K* KaNDY](https://millionrounds.com/company/kandy) ## Stage not reported 6 - [New Amsterdam Pharma](https://millionrounds.com/company/new-amsterdam-pharma) - [Crescent Biopharma](https://millionrounds.com/company/crescent-biopharma) - [bluebird bio](https://millionrounds.com/company/bluebird-bio) - [VectivBio](https://millionrounds.com/company/vectivbio) - [*GT* Gyroscope Therapeutics](https://millionrounds.com/company/gyroscope-therapeutics) - [Mestag Therapeutics](https://millionrounds.com/company/mestag-therapeutics) ## Pre-seed and seed 2 - [Tessellate BIO](https://millionrounds.com/company/tessellate-bio) - [*CT* CoviCept Therapeutics](https://millionrounds.com/company/covicept-therapeutics) ## Segment by segment ### Series B 23 startups · $2.5B raised - [**Expedition Therapeutics**](https://millionrounds.com/company/expedition-therapeutics) Expedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024. United States $280M - [**Marea Therapeutics**](https://millionrounds.com/company/marea-therapeutics) Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses. United States $190M - [*CT* **Capstan Therapeutics**](https://millionrounds.com/company/capstan-therapeutics) Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases. United States $175M - [**Mariana Oncology**](https://millionrounds.com/company/mariana-oncology) Mariana Oncology is a biotechnology research industry. United States $175M - [**AIRNA**](https://millionrounds.com/company/airna) AIRNA is a biotechnology company founded in 2021, focused on discovering and developing RNA editing therapeutics. United States $155M - [**Noema Pharma**](https://millionrounds.com/company/noema-pharma) Noema Pharma is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 by George Garibaldi and Luigi Costa. Switzerland $147M - [**Achilles Therapeutics**](https://millionrounds.com/company/achilles-therapeutics) Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. United Kingdom $143M - [**AAVantgarde Bio**](https://millionrounds.com/company/aavantgarde-bio) AAVantgarde Bio is developing gene therapies for inherited retinal disorders. Italy $141M ### Series A 16 startups · $2.4B raised - [**Dyne Therapeutics**](https://millionrounds.com/company/dyne-therapeutics) Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases. United States $828M - [**Verdiva Bio**](https://millionrounds.com/company/verdiva-bio) Verdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024. United Kingdom $601M - [**Braveheart Bio**](https://millionrounds.com/company/braveheart-bio) Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space. United States $185M - [**Slate Medicines**](https://millionrounds.com/company/slate-medicines) Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention. United States $130M - [*MM* **Memento Medicines**](https://millionrounds.com/company/memento-medicines) Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases. United Kingdom $93M - [**Calluna Pharma**](https://millionrounds.com/company/calluna-pharma) Calluna Pharma is a clinical-stage biotechnology company based in Oslo, Norway. Norway $81M - [**Corsera Health**](https://millionrounds.com/company/corsera-health) Corsera Health is a biotechnology company based in Boston, founded in 2025 by John Maraganore, Ph.D., and Clive Meanwell, M.D. United States $80M - [*MT* **Mosanna Therapeutics**](https://millionrounds.com/company/mosanna-therapeutics) Switzerland $80M ### Series C and later 7 startups · $930M raised - [**Beacon Therapeutics**](https://millionrounds.com/company/beacon-therapeutics) Beacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023, dedicated to saving and restoring vision United States $247M - [**AM Pharma**](https://millionrounds.com/company/am-pharma) AM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands. Netherlands $189M - [*B* **BioVex**](https://millionrounds.com/company/biovex) THOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquis United Kingdom $133M - [**SANIFIT**](https://millionrounds.com/company/sanifit) SANIFIT is a biotechnology company that develops treatments for patients with calcification disorders. Spain $122M - [**NorthSea Therapeutics**](https://millionrounds.com/company/northsea-therapeutics) NorthSea Therapeutics B.V. Netherlands $109M - [**Hookipa**](https://millionrounds.com/company/hookipa) Hookipa GmbH – Private Equity, Finanzierungen, Start-Up Coaching und Vermittlung von Kontakten & Personal. Austria $97M - [*K* **KaNDY**](https://millionrounds.com/company/kandy) United Kingdom $33M ### Stage not reported 6 startups · $1.1B raised - [**New Amsterdam Pharma**](https://millionrounds.com/company/new-amsterdam-pharma) New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. Netherlands $453M - [**Crescent Biopharma**](https://millionrounds.com/company/crescent-biopharma) Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines. United States $185M - [**bluebird bio**](https://millionrounds.com/company/bluebird-bio) bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. United States $151M - [**VectivBio**](https://millionrounds.com/company/vectivbio) VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases. Switzerland $125M - [*GT* **Gyroscope Therapeutics**](https://millionrounds.com/company/gyroscope-therapeutics) Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. United Kingdom $118M - [**Mestag Therapeutics**](https://millionrounds.com/company/mestag-therapeutics) Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology. United Kingdom $42M ### Pre-seed and seed 2 startups · $11M raised - [**Tessellate BIO**](https://millionrounds.com/company/tessellate-bio) Tessellate Bio is a preclinical-stage biotechnology company focused on developing innovative precision oncology medicines. Netherlands $8.5M - [*CT* **CoviCept Therapeutics**](https://millionrounds.com/company/covicept-therapeutics) CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses. - $2.3M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Forbion Capital Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Forbion Capital Partners portfolio map** 74 startups · $10B](https://millionrounds.com/portfolio-maps/forbion-capital-partners-portfolio-map)[Co-investors **Who invests with Forbion Capital Partners** 55 co-investors](https://millionrounds.com/portfolio-maps/forbion-capital-partners-co-investors)[Investments abroad **Forbion Capital Partners' investments in the United States** 25 startups · $4.6B](https://millionrounds.com/portfolio-maps/forbion-capital-partners-investments-united-states)[Investments abroad **Forbion Capital Partners' investments in the United Kingdom** 20 startups · $3.0B](https://millionrounds.com/portfolio-maps/forbion-capital-partners-investments-united-kingdom)[Sector portfolio **Gilde Healthcare's Biotech portfolio** 11 startups · $1.3B](https://millionrounds.com/portfolio-maps/gilde-healthcare-biotech-portfolio)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio) ## Raising from investors like Forbion Capital Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)